Medicenna Therapeutics Corp (MDNAF)

$0.83 +0.05 (6.45%)
Market Cap 49.97M
Revenue (ttm) 0.00
Net Income (ttm) -18.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 110,000
Avg Vol 62,692
Day's Range N/A - N/A
Shares Out 78.22M
Stochastic %K 58%
Beta 1.93
Analysts Strong Sell
Price Target $4.25

Latest News on MDNAF

No data available.